BENEFIT Act of 2023

Cost and committee reports

Official records Congress.gov attaches to H.R. 1092.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. MATSUI, as printed in the Congressional Record (Vol. 169, No. 33, February 17, 2023, Page H856):
  Article 1, Section 8 of the United States Constitution The single subject of this legislation is: To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
  Source: Congress.gov, Congressional Record February 17, 2023 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  207 characters

  Congress.gov bill record

  H.R. 1092, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/1092

  Record last updated by Congress.gov

  December 5, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  07733e37f738a4c4fc4fa88363e119306c1f7e598639825de9e5f7e857ed1d0b

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 5, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 1092, last updated December 5, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.